Maiguma Takayoshi, Kaji Hiroaki, Makino Kazutaka, Teshima Daisuke
Department of Clinical Pharmacy, School of Pharmacy, Shujitsu University, Okayama, Japan.
Basic Clin Pharmacol Toxicol. 2009 Jul;105(1):1-9. doi: 10.1111/j.1742-7843.2009.00400.x. Epub 2009 Apr 3.
Our study aimed to find more effective protective agents against mucosa toxicity induced by methotrexate and 5-fluorouracil. We focused on the relationship between oral mucositis and keratinocyte injury and examined methotrexate and 5-fluorouracil-induced cytotoxicity in normal human epidermal keratinocyte cell lines. Cell viability and superoxide radical activity were measured based on converting WST-1 (4-[3-(4-indophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzen disulfonate) to a water-soluble formazan dye. DNA synthesis by 5-bromo-2'-deoxyuridine incorporation was measured as an indirect parameter of cell proliferation. Allopurinol and amifostine were used as the radical scavengers. l-glutamine was used as a mucosa-protective agent. A cyclooxygenase inhibitor interrupting the production of hydroxyl radicals in the arachidonic acid cascade was also examined. 5-fluorouracil and methotrexate caused cytotoxicity due to the activation of intracellular superoxide radicals specifically on normal human epidermal keratinocytes. From the electron spin resonance study, it was found that allopurinol was a superoxide radical scavenger, while amifostine was hydroxyl radical scavenger. Allopurinol showed no effect on the cytotoxicity due to 5-fluorouracil and methotrexate. The cell injury induced by methotrexate was restored by amifostine. However, the cell injury induced by 5-fluorouracil was markedly recovered by a selective cyclooxygenase-1 inhibitor compared to amifostine. It was suggested that amifostine and cyclooxygenase-1 inhibitor could be useful protective agents against methotrexate and 5-fluorouracil chemotherapeutic toxicity. Additionally, this in vitro cell injury model using normal human epidermal keratinocytes may be useful for understanding the pathophysiology of oral mucositis induced by chemotherapeutic agents.
我们的研究旨在寻找更有效的抗甲氨蝶呤和5-氟尿嘧啶所致黏膜毒性的保护剂。我们聚焦于口腔黏膜炎与角质形成细胞损伤之间的关系,并检测了甲氨蝶呤和5-氟尿嘧啶对正常人表皮角质形成细胞系的细胞毒性。基于将WST-1(4-[3-(4-吲哚苯基)-2-(4-硝基苯基)-2H-5-四氮唑]-1,3-苯二磺酸盐)转化为水溶性甲臜染料来测定细胞活力和超氧自由基活性。通过5-溴-2'-脱氧尿苷掺入法测定DNA合成,以此作为细胞增殖的间接参数。别嘌醇和氨磷汀用作自由基清除剂。L-谷氨酰胺用作黏膜保护剂。还检测了一种中断花生四烯酸级联反应中羟基自由基产生的环氧化酶抑制剂。5-氟尿嘧啶和甲氨蝶呤通过细胞内超氧自由基的激活,对正常人表皮角质形成细胞产生细胞毒性。从电子自旋共振研究发现,别嘌醇是超氧自由基清除剂,而氨磷汀是羟基自由基清除剂。别嘌醇对5-氟尿嘧啶和甲氨蝶呤所致细胞毒性无作用。氨磷汀可恢复甲氨蝶呤所致的细胞损伤。然而,与氨磷汀相比,一种选择性环氧化酶-1抑制剂能显著恢复5-氟尿嘧啶所致的细胞损伤。提示氨磷汀和环氧化酶-1抑制剂可能是抗甲氨蝶呤和5-氟尿嘧啶化疗毒性的有用保护剂。此外,这种使用正常人表皮角质形成细胞的体外细胞损伤模型可能有助于理解化疗药物所致口腔黏膜炎的病理生理学。